300119.SZ
瑞普生物
SZSE · Healthcare · C 制造业 · CN
CNY 17.34
−3.24%Margins
Gross margin
40.9%
EBITDA margin
20.3%
EBIT margin
13.8%
Net margin
11.5%
FCF margin
2.1%
8.2%
Return on equity
5.0%
Return on assets
7.8%
Return on invested capital
0.44x
Asset turnover
CNY 235.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026